Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer
Clinical trial NCT04304248 · UNKNOWN
Trial details
- NCT number
- NCT04304248
- Sponsor
- Hao Long
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2026-07-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.